VRDN
7:00 AM
Viridian Therapeutics Announces Positive Topline Results from Elegrobart Phase 3 REVEAL‑2 Clinical Trial in Chronic Thyroid Eye Disease
Trial Results • Phase 3viridiantherapeutics.com
News Updates
Tue, May 5, 2026
1 updatesMon, Mar 30, 2026
1 updatesVRDN
7:01 AM
Viridian Therapeutics Announces Positive Topline Results from Elegrobart Phase 3 REVEAL‑1 Clinical Trial in Active Thyroid Eye Disease
Trial Results • Phase 3viridiantherapeutics.com